InsidersTradesSigma
Explore the detailed record of transactions filed by STAPLETON RAYMOND D JR, Chief Technology Officer. Officer active across 1 companies, notably Genocea Biosciences, INC.. Aggregated, 2 filings have been logged. Total volume traded: €208. The latest transaction was filed on 25 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations
Raymond D. Stapleton Jr. is the Chief Technology Officer at Genocea Biosciences, Inc. He oversees the company's technological development, ensuring innovation and product efficiency. His role is essential for supporting growth strategy and product development.